| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/25/2004 | US20040057984 Method for producing adhesive blanks from an endless band and blanks obtained according to said method |
| 03/25/2004 | US20040057983 Biomolecular wearable apparatus |
| 03/25/2004 | US20040057981 Gelled delivery vehicle containing nutritional ingredients |
| 03/25/2004 | US20040057980 Procedure and composition of treatment and/or care of the eye |
| 03/25/2004 | US20040057979 Methods for treating inflammation-mediated conditions of the eye |
| 03/25/2004 | US20040057972 By adjusting the pH of the composition to between 6.5 and about 8.1 |
| 03/25/2004 | US20040057970 Polyanhydrides |
| 03/25/2004 | US20040057946 Forming a solution of protein encapsulated, insoluble gas-filled microbubbles conjugated to biological agent; administering solution to animal; so that protein directs microbubble-conjugated agent to sites of bioprocessing |
| 03/25/2004 | US20040057944 For therapy and/or prophylaxis of maldigestion, especially maldigestion caused by pancreatic insufficiency, in humans or other mammals |
| 03/25/2004 | US20040057927 Formulations for IL-11 |
| 03/25/2004 | US20040057907 Dri-nasal sprays |
| 03/25/2004 | US20040057906 Perfluorocarbon emulsions with non-fluorinated surfactants |
| 03/25/2004 | US20040057905 Nanoparticulate beclomethasone dipropionate compositions |
| 03/25/2004 | US20040057900 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 03/25/2004 | US20040057899 Stabilised radiopharmaceutical compositions |
| 03/25/2004 | US20040056375 Method and apparatus for making miniature tablets |
| 03/25/2004 | US20040056372 Stabilizing a high concentrate drug content in water, by dissolving the drug and a polyetheramide copolymer in solvent, forming water in oil emulsion, volatilizing, desolventizing, supersonic treatment and ultrafiltration |
| 03/25/2004 | US20040055954 Method for the purification of marigold oleoresin |
| 03/25/2004 | US20040055875 Nanodevice for charged particle flow and method for producing same |
| 03/25/2004 | DE10243258A1 Composition for genital stimulation of women or men includes friction bodies |
| 03/25/2004 | DE10242088A1 Controlled release medicament, e.g. for parenteral administration of flupirtine, comprising drug, sucrose acetate-isobutyrate and mixture of solvents miscible and immiscible with sucrose acetate-isobutyrate |
| 03/25/2004 | DE10237057A1 Transdermal therapeutic systems containing buprenorphine, useful in treating pain or urinary incontinence, also containing mu-, kappa- or delta-opioid receptor antagonist to reduce abuse potential |
| 03/25/2004 | CA2799437A1 Method of producing hydroxyalkyl starch derivatives |
| 03/25/2004 | CA2499136A1 Accelerating recovery from trauma |
| 03/25/2004 | CA2498931A1 Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same |
| 03/25/2004 | CA2498930A1 Modified release oral dosage form |
| 03/25/2004 | CA2498784A1 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 03/25/2004 | CA2498777A1 Non-sequence complementary antiviral oligonucleotides |
| 03/25/2004 | CA2498757A1 Proline ester and preparation containing the same for percutaneous administration |
| 03/25/2004 | CA2498722A1 Method and device for painless injection of medication |
| 03/25/2004 | CA2498581A1 Thioredoxin composition and uses thereof for liquefaction of mucus or sputum |
| 03/25/2004 | CA2498410A1 Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin |
| 03/25/2004 | CA2498260A1 Pharmaceutical formulations of modafinil |
| 03/25/2004 | CA2497723A1 Method for preparation of microspheres and apparatus therefor |
| 03/25/2004 | CA2497494A1 Pectin films |
| 03/25/2004 | CA2496534A1 Method and apparatus for applying powder in a pattern to a substrate |
| 03/25/2004 | CA2496318A1 Hydroxyalkyl starch derivatives |
| 03/25/2004 | CA2496317A1 Method of producing hydroxyalkyl starch derivatives |
| 03/25/2004 | CA2495521A1 Methods of measuring the dissolution rates of an analyte in a non-aqueous liquid composition |
| 03/25/2004 | CA2495242A1 Hasylated polypeptides, especially hasylated erythropoietin |
| 03/24/2004 | EP1400533A1 HASylated polypeptides, especially HASylated erythropoietin |
| 03/24/2004 | EP1400512A1 Crystalline organic acid salt of amlodipine |
| 03/24/2004 | EP1400509A1 A method for the purification of marigold oleoresin |
| 03/24/2004 | EP1400258A1 Pharmaceutical composition delivery device and its manufacturing process |
| 03/24/2004 | EP1400240A1 Percutaneously absorbable patches |
| 03/24/2004 | EP1400239A1 Medicinal aerosol formulations of formoterol |
| 03/24/2004 | EP1399850A2 Hla ligand database utilizing predictive algorithms and methods of making and using same |
| 03/24/2004 | EP1399531A1 Methods and formulations for enhancing the dissolution of a solid material in liquid |
| 03/24/2004 | EP1399501A1 Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug |
| 03/24/2004 | EP1399485A1 Purification method of hydroxypropylmethyl cellulose phthalate |
| 03/24/2004 | EP1399436A2 Oxytocin agonists |
| 03/24/2004 | EP1399411A1 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies |
| 03/24/2004 | EP1399309A1 Method and device for producing compression coated tablets |
| 03/24/2004 | EP1399206A2 Hydrophobic dopamine agonists administered to the dermis |
| 03/24/2004 | EP1399205A2 Enhanced systemic absorption of intradermally delivered substances |
| 03/24/2004 | EP1399203A1 Nasal drug delivery devices |
| 03/24/2004 | EP1399190A1 Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers |
| 03/24/2004 | EP1399173A2 Pharmaceutical preparation containing active ingredients extracted from the plants centella asiatica, mahonia aquifolium and viola tricolor |
| 03/24/2004 | EP1399169A1 Exothermic formulations for the treatment of ectoparasites |
| 03/24/2004 | EP1399165A2 Stabilized dispersion of phytosterol in oil |
| 03/24/2004 | EP1399153A2 Pharmaceutical composition comprising a drug and a fatty acid or salt thereof |
| 03/24/2004 | EP1399152A1 Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester |
| 03/24/2004 | EP1399149A2 Taxane prodrugs |
| 03/24/2004 | EP1399145A2 Pressure sensitive adhesive matrix patch for the treatment of onychomycosis |
| 03/24/2004 | EP1399136A2 Process for the preparation of dispersions |
| 03/24/2004 | EP1399135A2 Methods for hermetically sealing microchip reservoir devices |
| 03/24/2004 | EP1399134A2 Differential delivery of nitric oxide |
| 03/24/2004 | EP1399133A2 Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same |
| 03/24/2004 | EP1399132A1 Production of hard, dense particles |
| 03/24/2004 | EP1399131A2 Spray freeze-dried compositions |
| 03/24/2004 | EP1399130A1 Emulsion and dispersion formulations and method |
| 03/24/2004 | EP1399129A1 Compositions with controlled release of lactic acid at vaginal level |
| 03/24/2004 | EP1399128A1 Composition for the treatment of diseases which affect animals' hooves |
| 03/24/2004 | EP1399127A1 Olopatadine formulations for topical administration |
| 03/24/2004 | EP1399120A1 Breath protection microcapsules |
| 03/24/2004 | EP1399119A2 Oral compositions and use thereof |
| 03/24/2004 | EP1399105A2 Method for cleaning hard gelatine capsules |
| 03/24/2004 | EP1399032A1 Improved hard sugar coating method |
| 03/24/2004 | EP1301176B1 Method for coating solid particles with a thermofusible agent, and resulting coated solid particles |
| 03/24/2004 | EP1242087B1 Analgesic compositions containing buprenorphine |
| 03/24/2004 | EP1190720B1 Liquid pharmaceutical composition for oral administration of bitter hydrolysis-susceptible active substances |
| 03/24/2004 | EP1150820B1 Injection molding method for neutral and acidic-group containing (meth)acrylate copolymers |
| 03/24/2004 | EP1128816B1 Polyvinyl alcohol microspheres, and methods for making of the same |
| 03/24/2004 | EP1094820B1 Use of bisphosphonates in the treatment of vascular restenosis |
| 03/24/2004 | EP1074250B1 Sugar coated tablets |
| 03/24/2004 | EP1045695B1 Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f 1? to treat peripheral vascular disease |
| 03/24/2004 | EP0948318B1 Granulates comprising a water soluble compound and cellulose |
| 03/24/2004 | EP0869773B1 Archaeosomes, archaeosomes containing coenzyme q 10, and other types of liposomes containing coenzyme q 10 as adjuvants and as delivery vehicles |
| 03/24/2004 | EP0784469B1 Compositions for the delivery of antigens |
| 03/24/2004 | EP0781134B1 Scopolamine plaster |
| 03/24/2004 | EP0759739B1 Improvements in dental floss |
| 03/24/2004 | EP0754031B1 Multilamellar drug delivery systems |
| 03/24/2004 | EP0725633B1 Capsule for detecting Helicobacter Pylori in the stomach |
| 03/24/2004 | CN2607134Y Citrene soft capsule medicine for curing biliary tract disease |
| 03/24/2004 | CN2607133Y External Chinese medicine form |
| 03/24/2004 | CN1484649A Stabilized pharmaceutical composition in lyophilized form |
| 03/24/2004 | CN1484534A Stabilised radiopharmaceutical composition |
| 03/24/2004 | CN1484532A Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens |
| 03/24/2004 | CN1484530A Use of enzymes obtainde from ciliates as medicaments for promoting digestion |
| 03/24/2004 | CN1484525A Combinations of drugs (E. G chlorpromazine and pentamidine) for the treatment of neoplastic disorders |